Functionalized polyethyleneimine composite material complexed with copper ions and application of functionalized polyethyleneimine composite material in cancer cell diagnosis and treatment

By combining functionalized hyperbranched polyethyleneimine with copper ions, a nanocomposite system was constructed, which solved the shortcomings of copper ions in tumor diagnosis and treatment, and achieved targeted CT/MR imaging and chemokinetic therapy, which improved Diagnostic and therapeutic efficacy.

CN119033969APending Publication Date: 2024-11-29NANJING TECH UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411157610.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The existing copper ions have defects in imaging mode in tumor diagnosis and treatment, with many artifacts, difficult to quantify, and poor tumor specificity, which limits their diagnostic and therapeutic efficacy.

Method used

By combining functionalized hyperbranched polyethyleneimine with copper ions, a nanocomposite system is constructed to realize targeted CT/MR imaging and chemokinetic therapy, folic acid modification is used to improve targeting, gold nanoparticles enhance CT imaging performance, copper Ion-catalyzed Fenton-like reaction produces reactive oxygen species.

Benefits of technology

Bimodal imaging and chemokinetic therapy targeting cancer cells are realized, which improves the accuracy and efficacy of tumor diagnosis and treatment, and has good biocompatibility and stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119033969A_ABST
    Figure CN119033969A_ABST
Patent Text Reader

Abstract

The invention discloses a functionalized polyethyleneimine composite material complexed with copper ions and application of the functionalized polyethyleneimine composite material in cancer cell diagnosis and treatment. According to the composite material, hyperbranched polyethyleneimine serves as a platform, targeting molecule folic acid is modified on the surface of the hyperbranched polyethyleneimine, gold nanoparticles are wrapped in the hyperbranched polyethyleneimine for functionalization, and then the functionalized hyperbranched polyethyleneimine and copper ions are effectively combined to construct a nano composite system. The prepared composite material can provide two kinds of imaging information at the same time, and targeted cancer cell CT / MR imaging is achieved; in addition, based on the ability of copper ion Fenton-like reaction to generate active oxygen, the copper ion Fenton-like reaction can also be used for cancer cell chemical kinetics therapy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biomedicine, and specifically relates to a functionalized polyethyleneimine composite material for complexing copper ions and an application thereof in the diagnosis and treatment of cancer cells. Background Art

[0002] So far, cancer is still the second leading cause of death after cardiovascular disease and remains a major disease threatening human health. In view of the high incidence and mortality of cancer, early diagnosis and early treatment of cancer are still effective means to cure cancer. Accurate diagnosis of cancer in the early stage can provide detailed information on cancer development and lesions, facilitate accurate staging treatment, and thus effectively cure cancer and reduce cancer deaths.

[0003] Nowadays, common non-invasive tumor diagnostic methods include: X-ray tomography (CT), magnetic resonance imaging (MR), ultrasound imaging (US), positron emission tomography (PET), single photon emission computed tomography (SPECT), etc. Each imaging method has different imaging characteristics due to different imaging principles. For example, CT imaging has the advantages of quantification and short imaging time, but it also has the disadvantages of low soft tissue contrast and sensitivity; MR imaging has the advantages of high sensitivity and arbitrary direction tomography, but the large number of artifacts during imaging is still a difficult problem to overcome. Therefore, although each imaging method has its own unique features, it also has its own imaging mode defects, making it difficult to diagnose tumors comprehensively, so it is necessary to further solve the problem of poor single imaging diagnosis of tumors.

[0004] With the advancement of science and technology, the treatment methods of tumors have been continuously enriched, such as surgical treatment, radiotherapy, chemotherapy, photodynamic therapy and chemodynamic therapy. However, traditional cancer treatment methods such as surgical treatment have disadvantages such as large side effects and high recurrence rate, which make the tumor treatment effect and prognosis poor. Therefore, the development of new tumor treatment methods based on the physiological characteristics of cancer has become a popular development direction. Among them, as one of the emerging cancer treatment methods, chemodynamic therapy (CDT) can produce Fenton / Fenton reactions in the slightly acidic environment of high glutathione (GSH) and high endogenous hydrogen peroxide (H2O2) in the tumor, thereby specifically producing reactive oxygen species, causing oxidative stress, and causing cancer cell apoptosis (Zhou, YF; Fan, SY et al. Adv Mater, 2021, 33 (48): 2104223). CDT has little dependence on external conditions, overcomes the limitations of tissue depth and hypoxia in the tumor microenvironment, and can also avoid side effects on normal organs of the human body during tumor treatment. Therefore, based on the excellent properties of CDT, many materials containing transition metals (iron, copper, manganese, cobalt, etc.) have been developed. Among them, the copper-catalyzed Fenton-like reaction can occur efficiently in weakly acidic or neutral media, and its maximum reaction rate is about 160 times that of the iron-mediated Fenton reaction rate. Therefore, copper plays an important role in CDT. Not only that, copper ions (Cu(II)) are paramagnetic due to the presence of lone pairs of electrons, and copper ion-based nanomaterials can also be used as MR imaging contrast agents (Song, C.; Ouyang, ZJ et al. Nano Today, 2021, 41: 101325). However, MR imaging has defects such as many artifacts and difficulty in quantification, making it difficult to fully display the physiological and pathological information of the tumor site; in addition, the poor tumor specificity of copper ions makes it low in the tumor site after circulating in the body, limiting the diagnosis and treatment of tumors. Therefore, in view of the defects in the application of copper ion tumor diagnosis and treatment, it is urgent to develop new biomedicines to improve the diagnosis and treatment of copper ions.

[0005] Fortunately, the rapid development of nanotechnology has made it possible to accurately diagnose and treat tumors mediated by copper ions. The construction of nano-diagnostic and therapeutic systems often requires the use of nano-carriers with excellent properties, such as hydrogels, polymer micelles, carbon nanotubes, hyperbranched polymers, etc. Among them, hyperbranched polyethyleneimine (PEI.NH2) has good biocompatibility and excellent physical and chemical properties, and has many terminal amino groups that can be functionally modified and internal cavities that can be used to load functional molecules. Therefore, it is widely used in the construction of different nano-diagnostic and therapeutic systems. For example, its surface is modified with targeting ligands for targeting lesions; modified tracers are used for cell uptake localization analysis; loaded with imaging reagents for tumor diagnosis; loaded with therapeutic drugs for inhibiting cancer cell growth, etc. (Li, JC; Yu, XR et al. Prog Mater Sci, 2022, 124: 100871). Not only that, multimodal imaging nanosystems such as CT / MR and CT / SPECT constructed based on hyperbranched polyethyleneimine can also reduce diagnostic errors and greatly enhance the accuracy of tumor diagnosis by complementing the advantages and synergizing the various diagnostic methods of tumors. These modified functionalized hyperbranched polyethyleneimine-based nanocomplexes can improve their tumor diagnostic and therapeutic efficacy by leveraging the excellent properties of PEI.NH2 (Zhao, C.; Zhou, BQ et al. J Funct Biomater, 2023, 14(1): 12).

[0006] Therefore, based on the excellent properties of hyperbranched polyethyleneimine and the application potential of copper ions in tumor diagnosis and treatment, the present invention is designed to effectively combine functionalized hyperbranched polyethyleneimine and copper ions to construct a nanocomposite system to achieve cancer cell targeted CT / MR imaging and chemodynamic therapy. Summary of the invention

[0007] One of the purposes of the present invention is to provide a functionalized polyethyleneimine composite material for complexing copper ions, which is prepared by the following steps:

[0008] Step 1, adding (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide to a dimethyl sulfoxide solution of folic acid for activation, and then adding the solution to a dimethyl sulfoxide solution of amino-polyethylene glycol-carboxyl for reaction to obtain FA-PEG-COOH;

[0009] Step 2, adding (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide to a solution of 2-picolinic acid in N'N-dimethylformamide for activation, and then adding the solution to an aqueous solution of hyperbranched polyethyleneimine for reaction to obtain PEI.NH2-PA;

[0010] Step 3, adding (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide to the aqueous solution of FA-PEG-COOH for activation, and then adding the solution to the aqueous solution of PEI.NH2-PA for activation to obtain PEI.NH2-(PEG-FA)-PA;

[0011] Step 4, adding the dimethyl sulfoxide solution of fluorescein isothiocyanate to the dimethyl sulfoxide solution of PEI.NH2-(PEG-FA)-PA, stirring and reacting in the dark to obtain PEI.NH2-FI-(PEG-FA)-PA;

[0012] Step 5, adding the aqueous solution of chloroauric acid to the aqueous solution of PEI.NH2-FI-(PEG-FA)-PA, adding the solution of sodium borohydride, stirring in the dark, and reacting with stirring in the dark; then adding triethylamine, stirring in the dark, and reacting, and then adding acetic anhydride, stirring in the dark, and reacting to obtain nanoparticles [(Au 0 ) 100 -PEI.NHAc-FI-(PEG-FA)-PA]NPs(FA-Au PENPs);

[0013] Step 6, adding the copper chloride aqueous solution to the aqueous solution of nanoparticles FA-Au PENPs while stirring and shielding from light, and ultrasonicating to prepare a functionalized polyethyleneimine composite material (FA-Au / Cu(II)PENPs) complexed with copper ions.

[0014] Furthermore, in step 1, the molar ratio of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, N-hydroxysuccinimide and folic acid is 1-1.5:1-1.5:1, and the molar ratio of folic acid to amino-polyethylene glycol-carboxyl is 1.2-1.5:1.

[0015] Furthermore, in step 2, the molar ratio of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, N-hydroxysuccinimide and 2-picolinic acid is 10-12:10-12:1, and the molar ratio of 2-picolinic acid to hyperbranched polyethyleneimine is 80-100:1.

[0016] Furthermore, in step 3, the molar ratio of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, N-hydroxysuccinimide and FA-PEG-COOH is 10-12:10-12:1, and the molar ratio of FA-PEG-COOH to PEI.NH2-PA is 20-25:1.

[0017] Furthermore, in step 4, the molar ratio of fluorescein isothiocyanate to PEI.NH2-(PEG-FA)-PA is 3-5:1.

[0018] Furthermore, in step 5, the molar ratio of chloroauric acid to PEI.NH2-FI-(PEG-FA)-PA is 100:1, the molar ratio of sodium borohydride to chloroauric acid is 3-5:1, and the molar ratio of triethylamine, acetic anhydride and PEI.NH2-FI-(PEG-FA)-PA is 120-660:100-550:1.

[0019] Furthermore, in step 6, the molar ratio of copper chloride to nanoparticles FA-Au PENPs is 60:1.

[0020] The second object of the present invention is to provide the use of the functionalized polyethyleneimine composite material complexed with copper ions in the preparation of tumor diagnosis and treatment reagents.

[0021] The present invention utilizes the advantages of the polyethyleneimine platform to perform functional modification on hyperbranched polyethyleneimine, including: (1) modifying the targeting ligand folic acid (FA) on the surface of the hyperbranched polyethyleneimine to achieve its targeting of FA receptor-highly expressed cancer cells, thereby achieving the purpose of specifically delivering FA-Au / Cu(II)PENPs to cancer cells; (2) using polyethylene glycol (PEG) to enhance the biocompatibility of the nanocomposite material, prolong the circulation time in the body, and increase the stability of gold nanoparticles encapsulated by the functionalized hyperbranched polyethyleneimine; (3) modifying FI on the surface of the hyperbranched polyethyleneimine so that it can be used as a fluorescent marker to play a fluorescent tracing role; (4) using NaBH4 to reduce HAuCl4 to prepare gold nanoparticles, and using the hydrophobic cavity of the functionalized hyperbranched polyethyleneimine to encapsulate the gold nanoparticles, thereby giving the nanocomposite material CT imaging tumor diagnosis function; (5) acetylation of the remaining amino groups on the surface of the functionalized hyperbranched polyethyleneimine to reduce the surface potential and improve the biocompatibility of the composite material; (6) combining copper ions with FA-Au PENPs complexation can simultaneously endow the composite material with MR imaging properties and chemodynamic therapeutic capabilities.

[0022] The FA-Au / Cu(II)PENPs prepared by the present invention can provide two kinds of imaging information at the same time, and realize targeted cancer cell CT / MR imaging; moreover, based on the ability of copper ions to generate active oxygen through Fenton-like reaction, FA-Au / Cu(II)PENPs can also be used for cancer cell chemodynamic therapy. Therefore, the FA-Au / Cu(II)PENPs nanocomposite prepared by the present invention has a good use value in the early diagnosis and treatment of cancer cells.

[0023] Beneficial Effects

[0024] (1) The FA-Au / Cu(II)PENPs prepared by the present invention are simple in synthesis, easy to operate, and have mild reaction conditions, and have good biomedical application value.

[0025] (2) The modification of FA in the present invention can increase the uptake of FA-Au / Cu(II)PENPs nanocomposite materials by cancer cells with high FA receptor expression; copper ions have paramagnetism and produce ·OH by the Fenton-like reaction, which endows FA-Au / Cu(II)PENPs nanodiagnostic and therapeutic agents with the ability of MR imaging and chemodynamic treatment of cancer cells; gold nanoparticles have a higher atomic number, which makes FA-Au / Cu(II)PENPs nanodiagnostic and therapeutic agents have good CT imaging performance. These advantages enable cancer cells with high FA receptor expression to specifically uptake FA-Au / Cu(II)PENPs nanocomposite materials, while achieving CT / MR dual-modality imaging and chemodynamic treatment of cancer cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 Schematic diagram of the synthesis of FA-Au / Cu(II)PENPs prepared in the present invention.

[0027] Figure 2 The (a) FA-PEG-COOH, (b) PEI.NH2-PA, (c) PEI.NH2-(PEG-FA)-PA, (d) PEI.NH2-FI-(PEG-FA)-PA, (e) PEI.NH2-mPEG-PA and (f) PEI.NH2-FI-mPEG-PA prepared in the present invention were dissolved in D2O. 1 H NMR spectrum.

[0028] Figure 3 UV-Vis spectra of (a) FA-PEG-COOH, PEI.NH2-PA, PEI.NH2-(PEG-FA)-PA and PEI.NH2-FI-(PEG-FA)-PA prepared in the present invention dissolved in water, (b) UV-Vis spectrum of FA-Au / Cu(II)PENPs dissolved in water, and the inset is a digital photograph of FA-Au / Cu(II)PENPs dissolved in water.

[0029] Figure 4 UV-Vis spectra of (a) PEI.NHAc-FI-(PEG-FA)-PA and (c) PEI.NHAc-FI-mPEG-PA prepared in the present invention after complexation with different molar equivalents of CuCl2. (b) Fitting curve of the molar ratio of Cu(II) to PEI.NHAc-FI-(PEG-FA)-PA and (d) Cu(II) to PEI.NHAc-FI-mPEG-PA and absorbance at a specific wavelength.

[0030] Figure 5(a) TEM image, (b) particle size distribution histogram, (c) high-resolution TEM image and (d) selected area electron diffraction (SAED) image of FA-Au / Cu(II)PENPs prepared in the present invention.

[0031] Figure 6 (a) XPS full spectrum analysis and (b) Cu 2p XPS spectrum of FA-Au / Cu(II)PENPs prepared in the present invention.

[0032] Figure 7 (a) FT-IR spectra of GSH, GSSG, and FA-Au / Cu(II)PENPs+GSH prepared in the present invention; (b) UV-Vis spectra of the reaction of solutions of FA-Au / Cu(II)PENPs and GSH mixed or not with the new copper reagent; (c) UV-Vis spectra of the reaction of GSH with DTNB after consumption by FA-Au / Cu(II)PENPs under different pH conditions; (d) UV-Vis spectra of CuCl2, FA-Au / Cu(II)PENPs, CuCl2+GSH+H2O2, and FA-Au / Cu(II)PENPs+GSH+H2O2 mixed with MB aqueous solution for 2 h, respectively; (e) degradation curve of MB over time after mixing with FA-Au / Cu(II)PENPs+GSH+H2O2; (f) The remaining amount of MB in FA-Au / Cu(II)PENPs+GSH+H2O2 under different pH conditions.

[0033] Figure 8 This is the hydrated particle size distribution diagram of FA-Au / Cu(II)PENPs prepared in the present invention.

[0034] Fig. 9 UV-Vis spectra of FA-Au / Cu(II)PENPs measured at (a) different time points and (b) different temperatures.

[0035] Fig.10 (a) Hydration particle size and (b) polydispersity coefficient of FA-Au / Cu(II)PENPs dispersed in water and PBS at different time points, respectively.

[0036] Fig.11 Figure 2 Flow cytometry test results and (f) mean fluorescence intensity analysis of 4T1-HFAR cells incubated with (a) PBS, (b) 4T1-LFAR and (c) 4T1-HFAR cells incubated with Au / Cu(Ⅱ)PENPs, and (d) 4T1-LFAR and (e) 4T1-HFAR cells incubated with FA-Au / Cu(Ⅱ)PENPs for 2 h.

[0037] Fig.12CLSM images of 4T1-LFAR and 4T1-HFAR cells treated with PBS, Au / Cu(Ⅱ)PENPs and FA-Au / Cu(Ⅱ)PENPs for 2 h, respectively.

[0038] Fig.13 ICP-OES test results of 4T1-LFAR and 4T1-HFAR cells incubated with FA-Au / Cu(II)PENPs with different Au concentrations ([Au]=0, 50, 100, 200 μM) for 2 h.

[0039] Fig.14 (a) CT images and (b) corresponding CT values ​​of 4T1 cells after incubation with (1) Au / Cu(II)PENPs and (2) FA-Au / Cu(II)PENPs with different Au concentrations ([Au] = 0, 25, 50, 100, 200 μM) for 2 h.

[0040] Fig.15 (a) MR images and (b) corresponding MR values ​​of 4T1 cells after incubation with (1) Au / Cu(II)PENPs and (2) FA-Au / Cu(II)PENPs with different Cu concentrations ([Cu] = 0, 25, 50, 100, 150 μM) for 2 h.

[0041] Fig.16 Cell activity of 4T1 cells after incubation for 24 h with (a) FA-Au PENPs and Au PENPs with different PEI.NH2 concentrations and (b) FA-Au / Cu(II)PENPs, Au / Cu(II)PENPs, and CuCl2 with different Cu concentrations.

[0042] Fig.17 The morphologies of 4T1 cells after incubation for 24 h with (a) PBS, (b) Au PENPs and (c) FA-Au PENPs with PEI.NH2 concentration of 16 μM, (d) CuCl2 with Cu concentration of 1000 μM, (e) Au / Cu(II)PENPs and (f) FA-Au / Cu(II)PENPs, respectively.

[0043] Fig.18 (a) Flow cytometric apoptosis analysis of 4T1 cells after incubation with CuCl2 and FA-Au / Cu(II)PENPs with different Cu concentrations for 24 h, and the corresponding percentages of (b) living cells, (c) early apoptotic cells, and (d) late apoptotic cells.

[0044] Fig.19(a) Characterization diagram of intracellular reactive oxygen species and (b) corresponding quantitative analysis of 4T1 cells incubated with CuCl2 and FA-Au / Cu(II)PENPs with different Cu concentrations for 5 h.

[0045] Fig. 20 The hemolysis rate of red blood cells after being treated with FA-Au / Cu(II)PENPs with different Cu concentrations for 2 hours and the sample photos are shown. The red blood cells treated with H2O and PBS were used as positive and negative controls, respectively. The rightmost centrifuge tube in the sample photo is a FA-Au / Cu(II)PENPs ([Cu] = 40 μg / mL) solution sample without red blood cells. DETAILED DESCRIPTION

[0046] The preferred embodiments of the present invention will be described in detail below in conjunction with examples. It should be understood that the following examples are provided only for the purpose of illustration and are not intended to limit the scope of the present invention. Those skilled in the art may make various modifications and substitutions to the present invention without departing from the purpose and spirit of the present invention.

[0047] Unless otherwise specified, the experimental methods used in the following examples are conventional methods.

[0048] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0049] Example 1

[0050] Step 1, weigh 33.1 mg of FA and dissolve it in 8 mL of DMSO solution, add 2 mL of EDC DMSO solution (7.3 mg / mL) and 2 mL of NHS DMSO solution (4.4 mg / mL) in sequence while stirring to activate the FA carboxyl group for 2-3 hours. Then add the above solution to 10 mL of NH2-PEG-COOH (Mw=2000) DMSO solution (10 mg / mL), stir at room temperature for 2-3 days. Among them, the molar ratio of FA to EDC and NHS is 1:1:1, and the molar ratio of FA to NH2-PEG-COOH is 1.5:1. After the reaction is completed, a dialysis bag with a molecular weight cutoff of 1000 is selected to dialyze the above reaction solution in distilled water for 3 days, and then freeze-dry to obtain FA-PEG-COOH dry powder.

[0051] Step 2, weigh 98.5mg of PA-COOH and dissolve it in 20mL of DMF, add 50mL of EDC DMF solution (30.7mg / mL), 20mL of NHS DMF solution (48mg / mL) to activate the carboxyl group of PA-COOH for 2-3 hours. After activation, slowly add the activated PA-COOH solution to 10mL PEI.NH2 aqueous solution (20mg / mL), stir at room temperature for 2-3 days, wherein the molar ratio of PA-COOH to EDC and NHS is 1:10:10, and the molar ratio of PA-COOH to PEI.NH2 is 100:1. After the reaction is completed, a dialysis bag with a molecular weight cutoff of 8000-14000 is selected to dialyze the reaction solution in distilled water for 3 days, followed by freeze drying to obtain PEI.NH2-PA dry powder.

[0052] Step 3, 94.3mg of the above-obtained FA-PEG-COOH dry powder was dissolved in 10mL ultrapure water, and 5mL EDC aqueous solution (16.1mg / mL) and 5mL NHS aqueous solution (9.9mg / mL) were added successively for activation for 2-3 hours. After activation, it was added to 6mL PEI.NH2-PA aqueous solution (10mg / mL), and stirred at room temperature for 2-3 days. Among them, the molar ratio of FA-PEG-COOH to EDC and NHS was 1:10:10, and the molar ratio of FA-PEG-COOH to PEI.NH2-PA was 20:1. After the reaction was completed, a dialysis bag with a molecular weight cutoff of 8000-14000 was selected to dialyze the above-obtained reaction solution in distilled water for 3 days, followed by freeze drying to obtain PEI.NH2-(PEG-FA)-PA dry powder.

[0053] Step 4, dissolve 1.05 mg of FI powder in 2 mL of DMSO, add it to 5 mL of PEI.NH2-(PEG-FA)-PA DMSO solution (9.5 mg / mL), stir and react for 1 day in the dark. The molar ratio of PEI.NH2-(PEG-FA)-PA to FI is 1:5. After the reaction, use a dialysis bag with a molecular weight cutoff of 8000-14000 to dialyze the reaction solution in distilled water in the dark for 3 days, then freeze-dry to obtain PEI.NH2-FI-(PEG-FA)-PA.

[0054] Step 5: Slowly add 5 mL of HAuCl4 aqueous solution (2.9 mg / mL) to 5 mL of PEI.NH2-FI-(PEG-FA)-PA aqueous solution (9.5 mg / mL), stir and react for 30 minutes in the dark, then quickly add 1 mL of NaBH4 solution (4.9 mg / mL, V 甲醇 :V水 =1:2), and react for 2 hours with stirring in the dark. After the reaction is completed, 57.0μL N(C2H5)3 is added and stirred in the dark for 30 minutes, and then 32.1μL Ac2O is added and stirred in the dark for 1 day. Among them, the molar ratio of PEI.NH2-FI-(PEG-FA)-PA to HAuCl4 and NaBH4 is 1:100:300, and the molar ratio of PEI.NH2-FI-(PEG-FA)-PA to N(C2H5)3 and Ac2O is 1:600:500. After the reaction is completed, a dialysis bag with a molecular weight cutoff of 8000-14000 is used to dialyze the reaction solution obtained above in distilled water in the dark for 3 days, and then freeze-drying is performed to obtain a dry nanocomposite material [(Au 0 ) 100 -PEI.NHAc-FI-(PEG-FA)-PA]NPs(FA-Au PENPs).

[0055] Step 6, 1 mL of CuCl2 aqueous solution (4.4 mg / mL) was added to 3 mL of FA-Au PENPs aqueous solution (10 mg / mL) while stirring and shielding from light, and ultrasonicated for 10 minutes. The reaction solution was freeze-dried to prepare the final product FA-Au / Cu(II)PENPs. The molar ratio of CuCl2 to FA-Au PENPs was 60:1.

[0056] Comparative Example 1

[0057] Step 1, 85.6 mg of mPEG-COOH (Mw = 2000) was dissolved in 10 mL of ultrapure water, and 5 mL of EDC aqueous solution (16.4 mg / mL) and 5 mL of NHS aqueous solution (9.9 mg / mL) were added in turn for activation for 2-3 hours. After activation, it was added to 6 mL of an aqueous solution (10 mg / mL) of the intermediate product PEI.NH2-PA synthesized in Example 1, and stirred at room temperature for 2-3 days. Among them, the molar ratio of mPEG-COOH to EDC and NHS was 1:10:10, and the molar ratio of mPEG-COOH to PEI.NH 2- The molar ratio of PA is 20: 1. After the reaction is completed, the reaction solution is dialyzed in distilled water for 3 days using a dialysis bag with a molecular weight cutoff of 8000-14000, and then freeze-dried to obtain PEI.NH2-mPEG-PA dry powder.

[0058] Step 2, dissolve 0.63 mg of FI powder in 2 mL of DMSO, add it to 5 mL of PEI.NH2-mPEG-PA DMSO solution (5.7 mg / mL), stir and react for 1 day in the dark. The molar ratio of PEI.NH2-mPEG-PA to FI is 1:5. After the reaction, use a dialysis bag with a molecular weight cutoff of 8000-14000 to dialyze the reaction solution in distilled water in the dark for 3 days, then freeze-dry it to obtain PEI.NH2-FI-mPEG-PA.

[0059] Step 3, 5 mL of HAuCl4 aqueous solution (2.3 mg / mL) was slowly added to 5 mL of PEI.NH2-FI-mPEG-PA aqueous solution (7.6 mg / mL), stirred in the dark for 30 minutes, and then 1 mL of NaBH4 solution (3.9 mg / mL, V 甲醇 :V 水 =1:2), stir and react for 2 hours in the dark. After the reaction is completed, add 43.8μL N(C2H5)3 and stir to react for 30 minutes in the dark, then add 24.8μL Ac2O and continue to stir and react for 1 day in the dark. Among them, the molar ratio of PEI.NH2-FI-mPEG-PA to HAuCl4 and NaBH4 is 1:100:300, and the molar ratio of PEI.NH2-FI-mPEG-PA to N(C2H5)3 and Ac2O is 1:600:500. After the reaction is completed, a dialysis bag with a molecular weight cutoff of 8000-14000 is selected to dialyze the reaction solution obtained above in distilled water in the dark for 3 days, and then freeze-drying is performed to obtain a dry nanocomposite material [(Au 0 ) 100 -PEI.NHAc-FI-mPEG-PA]NPs (AuPENPs).

[0060] Step 4, 1 mL of CuCl2 aqueous solution (4 mg / mL) was added to 3 mL of Au PENPs aqueous solution (9.1 mg / mL) while stirring and shielding from light, and ultrasonicated for 10 minutes. Finally, the reaction solution was freeze-dried to prepare the final product Au / Cu(II)PENPs. The molar ratio of CuCl2 to Au PENPs was 60:1.

[0061] The following uses the hydrogen nuclear magnetic resonance spectrum ( 1The prepared FA-Au / Cu(II)PENPs were basically characterized by H NMR, ultraviolet-visible absorption spectroscopy (UV-Vis), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FT-IR), X-ray photoelectron spectroscopy (XPS), and dynamic light scattering (DLS) tests. The targeting cancer cell ability, in vitro cancer cell treatment effect, targeted cancer cell CT / MR imaging, ability to induce ROS production, cancer cell apoptosis, and blood compatibility of FA-Au / Cu(II)PENPs were evaluated by flow cytometry, confocal laser scanning microscopy (CLSM), inductively coupled plasma optical emission spectroscopy (ICP-OES), cell proliferation-toxicity (CCK-8) test, inverted biological microscope, cell CT / MR imaging analysis, cell apoptosis test, intracellular reactive oxygen species (ROS) analysis, and hemolysis tests.

[0062] The specific test results are as follows:

[0063] (1) 1 H NMR test results

[0064] like Figure 2 As shown, through 1 The characteristic peaks in the H NMR spectrum were assigned, proving that the intermediate products: FA-PEG-COOH, PEI.NH2-PA, PEI.NH2-(PEG-FA)-PA, PEI.NH2-FI-(PEG-FA)-PA, PEI.NH2-mPEG-PA and PEI.NH2-FI-mPEG-PA were successfully synthesized. Subsequently, the characteristic peaks were integrated and calculated to find that each molecule of FA-PEG-COOH was modified with 0.5 FA, each molecule of PEI.NH2-FI-(PEG-FA)-PA was modified with 23.0 PA-COOH, 15.6 FA-PEG-COOH, 7.8 FA and 2.2 FI on the surface; each molecule of PEI.NH2-FI-mPEG-PA was modified with 23.0 PA-COOH, 15.8 mPEG-COOH and 2.0 FI on the surface.

[0065] (2) UV-Vis test results

[0066] like Figure 3As shown in the UV-Vis spectra, the UV-Vis spectra of FA-PEG-COOH, PEI.NH2-(PEG-FA)-PA and PEI.NH2-FI-(PEG-FA)-PA all have absorption peaks at 278 and 360nm, which belong to the UV-visible characteristic absorption peak of FA, indicating that FA is successfully modified on PEI.NH2-FI-(PEG-FA)-PA. In addition, the UV-Vis spectrum of PEI.NH2-FI-(PEG-FA)-PA has a UV-visible absorption peak at 265nm belonging to PA-COOH, and a UV-visible absorption peak at 511nm belonging to FI, indicating that FI and PA-COOH are also successfully modified on the surface of functionalized PEI.NH2 to form PEI.NH2-FI-(PEG-FA)-PA( Figure 3 After encapsulating gold nanoparticles and complexing copper ions, the UV-Vis spectrum of the formed FA-Au / Cu(II)PENPs showed a strong absorption peak at 502nm, which was attributed to the surface plasmon resonance (SPR) peak of gold nanoparticles, thus proving that gold nanoparticles were successfully encapsulated into functionalized polyethyleneimine ( Figure 3 (b)

[0067] (3) Test results of copper ion complexing ability

[0068] To evaluate the ability of PEI.NHAc-FI-(PEG-FA)-PA and PEI.NHAc-FI-mPEG-PA to complex copper ions, different molar equivalents of CuCl2 were added to PEI.NHAc-FI-(PEG-FA)-PA and PEI.NHAc-FI-mPEG-PA solutions, respectively. After rapid complexation, quantitative analysis was performed using UV-Vis spectroscopy. The results are shown in the attached manual. Figure 4 As shown in the figure, first, when PEI.NHAc-FI-(PEG-FA)-PA complexes copper ions, after adding different molar equivalents (20, 40, 60, 80, 100, 120, 140 and 160) of CuCl2, it can be seen from the UV-Vis spectrum that PEI.NHAc-FI-(PEG-FA)-PA / Cu 2+ The complex showed a UV-visible absorption peak at 656nm. And with the increase of CuCl2 addition, the absorbance of the copper ion complex at 656nm also gradually increased. However, when the molar equivalent of CuCl2 added exceeded a certain value, the absorption peak of the copper ion complex red-shifted, which may be due to the excess copper ions from PEI.NHAc-FI-(PEG-FA)-PA / Cu 2+ The complex system is freed from Figure 4Therefore, in order to maximize the possibility of complexing copper ions into the functionalized polyethyleneimine system and prevent copper ions from being released from the system, PEI.NHAc-FI-(PEG-FA)-PA / Cu 2+ The absorbance value of the complex at 656 nm was nonlinearly fitted with the molar ratio of copper ions to functionalized polyethyleneimine, and it was found that each molecule of functionalized polyethyleneimine could complex approximately 60 molar equivalents of copper ions ( Figure 4 b). Similarly, similar analysis was performed on the non-targeted material PEI.NHAc-FI-mPEG-PA, and it was found that each functionalized polyethyleneimine molecule can complex approximately 60-70 molar equivalents of copper ions ( Figure 4 c and d). Therefore, the present invention subsequently uses FA-Au / Cu(II)PENPs complexed with 60 molar equivalents of copper ions for research.

[0069] (4) Morphology test results

[0070] The FA-Au / Cu(II)PENPs in Example 1 were dissolved in ultrapure water to prepare an aqueous solution with a concentration of 1 mg / mL, and observed by TEM. Figure 5 As shown in Figure 2, FA-Au / Cu(II)PENPs were found to be spherical in shape with a normal distribution of particle sizes, with an average particle size of 2.87±0.52nm ( Figure 5 Through high-resolution TEM characterization, it was found that FA-Au / Cu(II)PENPs have a clear two-dimensional lattice structure ( Figure 5 Moreover, four clear characteristic rings (111), (200), (220), and (311) of the gold nanoparticles can be observed by selected area electron diffraction, indicating that the synthesized FA-Au / Cu(II)PENPs have a face-centered cubic crystal structure ( Figure 5 (d)

[0071] (5) X-ray photoelectron spectroscopy test results

[0072] like Figure 6 As shown in the X-ray photoelectron spectrum of FA-Au / Cu(II)PENPs, there are characteristic photoelectron lines of O1s, C 1s, N 1s, Cu2p, and Au 4f, indicating the presence of gold and copper elements in FA-Au / Cu(II)PENPs, indicating that FA-Au / Cu(II)PENPs successfully encapsulates gold nanoparticles and complexes copper ions ( Figure 6 In addition, the fine XPS scanning of copper element shows the presence of Cu 2P at 953.2 eV. 1 / 2 Peak, Cu 2P exists at 933.4eV 3 / 2peak, and a copper satellite peak appeared at 943.1eV. The above results show that after complexing into FA-Au PENPs, copper ions mainly exist in divalent form ( Figure 6 (b)

[0073] (6) Study on Fenton-like reaction process in vitro

[0074] In order to verify the process of copper ions consuming GSH and undergoing a Fenton-like reaction with H2O2 in the environment of high GSH and high endogenous H2O2 in cancer cells, the FT-IR and UV-Vis spectra of FA-Au / Cu(II)PENPs in Example 1 after reacting with different reagents under different conditions were tested.

[0075] First, 5 mL of FA-Au / Cu(II)PENPs ([Cu] = 10 mM) and 5 mL of GSH (10 mM) were mixed in equal volumes. After five minutes of reaction, the resulting reaction solution was freeze-dried and the freeze-dried product was tested using FT-IR spectroscopy. Figure 7 As shown in a, by comparing with the FT-IR spectrum of GSH, it was found that the original -1 The -SH stretching vibration peak attributable to GSH disappeared, and its spectrum was similar to that of commercial oxidized glutathione (GSSG), indicating that GSH was oxidized to GSSG by FA-Au / Cu(II)PENPs. Secondly, the new copper reagent was used to test the production of cuprous ions. 2 mL of FA-Au / Cu(II)PENPs ([Cu] = 10 mM) solution was mixed with 2 mL of GSH (10 mM) solution in equal volumes. After five minutes of reaction, 4 mL of the new copper reagent (10 mM) was added, mixed thoroughly and allowed to stand for five minutes before UV-Vis testing. It was found that the product had an obvious UV-visible absorption peak at 461 nm attributable to cuprous ions, while FA-Au / Cu(II)PENPs had no absorption peak at 461 nm after being mixed with the new copper reagent alone, indicating that after the reaction of FA-Au / Cu(II)PENPs with GSH, the complexed divalent copper ions were reduced to cuprous ions ( Figure 7b). In addition, since 2-nitro-5-mercaptobenzoic acid (TNB) produced by the reaction of 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) with GSH can show a characteristic UV-visible absorption peak at 412nm, DTNB is often used as a GSH detection indicator to evaluate the residual GSH content. At different pH values ​​(5.0, 6.5, 7.4), 2mL of FA-Au / Cu(II)PENPs ([Cu] = 10mM) was incubated with 3mL of GSH (10mM) for 30 minutes, and then 3mL of DTNB (10mM) was added, mixed thoroughly and incubated for two minutes. DTNB was used to react with the remaining GSH, and finally the residual GSH content was tested by UV-Vis spectroscopy. Figure 7 As shown in Figure c, the absorbance of the reaction product at 412 nm gradually decreased with the decrease of pH, indicating that acidic conditions prompted FA-Au / Cu(II)PENPs to release more copper ions to consume more GSH.

[0076] Since excessive ROS will cause the absorption peak of methylene blue (MB) at 665nm to be significantly weakened, MB degradation experiments are often used to detect whether ROS are generated. First, different solutions were prepared, including MB (10μg / mL), H2O2 (10mM), GSH (10mM), CuCl2 (10mM) and FA-Au / Cu(II)PENPs ([Cu] = 10mM). Subsequently, equal volumes (1mL) of solution were mixed according to the following groups: MB, CuCl2+MB, CuCl2+GSH+H2O2+MB, FA-Au / Cu(II)PENPs+MB and FA-Au / Cu(II)PENPs+GSH+H2O2+MB. After incubation for 2 hours, UV-Vis spectra were scanned for the above reaction solutions. Figure 7 As shown in Figure d, when FA-Au / Cu(II)PENPs were mixed with MB, the absorption peak of MB did not decrease. However, when FA-Au / Cu(II)PENPs were mixed with MB in the presence of GSH and H2O2, the absorbance of MB at a wavelength of 665nm was significantly reduced, indicating that FA-Au / Cu(II)PENPs can effectively produce hydroxyl radicals (·OH) to degrade MB in an environment simulating high GSH and high endogenous H2O2 in cancer cells. At the same time, under the above-mentioned conditions of FA-Au / Cu(II)PENPs coexisting with GSH and H2O2 and mixed with MB, the mixed solutions were tested to obtain UV-Vis spectra at different incubation time points (0, 30, 60, 90, and 120 minutes). The degradation curve of MB over time is shown in Figure 2. Figure 7As shown in Figure e, the absorbance of MB at 665nm shows a decreasing trend with time, indicating that the content of ·OH produced gradually increases with time. In addition, by studying the degradation effect of FA-Au / Cu(II)PENPs+GSH+H2O2 on MB under different pH conditions (5.0, 6.5, 7.4), it was found that the residual amount of MB also decreased significantly with the decrease of pH, indicating that the acidic environment is conducive to the production of more ·OH by FA-Au / Cu(II)PENPs, thereby leading to more MB degradation ( Figure 7 f).

[0077] (7) Stability test results

[0078] The FA-Au / Cu(II)PENPs in Example 1 were prepared into an aqueous solution with a concentration of 0.1 mg / mL. Dynamic light scattering analysis showed that the hydrated particle size of the FA-Au / Cu(II)PENPs was uniformly distributed, and the hydrated particle size was about 222.2±21.7 nm. Figure 8 As shown. By testing the UV-Vis spectrum of the FA-Au / Cu(II)PENPs aqueous solution in Example 1, its colloidal stability dissolved in ultrapure water was detected. 8 portions of FA-Au / Cu(II)PENPs were weighed respectively, dissolved in water to obtain 8 portions of FA-Au / Cu(II)PENPs solution (1 mg / mL), 4 portions were placed for 1, 3, 5, and 7 days respectively for UV-Vis spectrum testing, and the remaining 4 portions were placed at different ambient temperatures (4, 25, 37, 50°C) and then subjected to UV-Vis spectrum testing. It can be seen from the UV-Vis spectrum results of the FA-Au / Cu(II)PENPs solution that the SPR peak type of gold nanoparticles remained consistent at different time points (1, 3, 5, 7 days) and different temperatures (4, 25, 37, 50°C), and no obvious deviation occurred, as shown in FIG. Fig. 9 In addition, 2 portions of FA-Au / Cu(II)PENPs in Example 1 were weighed and dissolved in ultrapure water and PBS, respectively, to prepare water and PBS solutions of FA-Au / Cu(II)PENPs with a concentration of 0.05 mg / mL. The hydrated particle size and polydispersity index (PDI) of the water and PBS solutions of FA-Au / Cu(II)PENPs at 1, 3, 5, and 7 days were characterized by dynamic light scattering tests. The results showed that the hydrated particle size and PDI at different time points (1, 3, 5, and 7 days) did not change significantly, as shown in FIG. Fig.10 The above experiments show that FA-Au / Cu(II)PENPs still have good colloidal stability over a long period of time, at different temperatures or in different solvents.

[0079] (8) Flow cytometry test results

[0080] In order to verify that the modification of the targeting ligand FA can increase the uptake of FA-Au / Cu(II)PENPs by cancer cells, flow cytometry was used to analyze the targeted uptake of FA-Au / Cu(II)PENPs in Example 1 by 4T1 cells with high expression of FA receptors. First, the 4T1 cells inoculated in a 12-well plate after adherent growth were divided into two groups, one group was added with a medium containing FA (2.5 μM), and the other group was added with an equal volume of medium without FA and incubated for 2 hours. The culture medium was removed, and the 4T1 cells were washed 2-3 times with PBS to obtain 4T1 cells with low expression of folate receptor (4T1-LFAR) and 4T1 cells with high expression of folate receptor (4T1-HFAR). Subsequently, FA-Au / Cu(II)PENPs, Au / Cu(II)PENPs and PBS culture medium containing 5 μM were added to the above 4T1-LFAR and 4T1-HFAR cells, respectively, and incubated for 2 hours. After the incubation, the culture medium was removed and washed 2-3 times with PBS. Trypsin was added to digest the cells for 3-5 minutes, and then fresh culture medium was added to terminate the digestion and the suspended cells were blown. After centrifugation, a total of 5 groups of cells were obtained, including: 4T1-LFAR cells and 4T1-HFAR cells incubated with FA-Au / Cu(II)PENPs culture medium, 4T1-LFAR cells and 4T1-HFAR cells incubated with Au / Cu(II)PENPs culture medium, and 4T1-HFAR cells incubated with PBS culture medium, with three parallel samples in each group. Finally, 10 4 Cell samples. Flow cytometry test results are as follows Fig.11 As shown in the figure, compared with 4T1-HFAR cells incubated with PBS, 4T1-LFAR and 4T1-HFAR cells incubated with Au / Cu(Ⅱ)PENPs had weak fluorescence signals, indicating that Au / Cu(Ⅱ)PENPs could be non-specifically absorbed by 4T1 cells through cellular endocytosis and diffusion ( Fig.11 In addition, the fluorescence signal of 4T1-HFAR cells treated with FA-Au / Cu(II)PENPs was significantly higher than that of 4T1-LFAR cells treated with FA-Au / Cu(II)PENPs, and also higher than that of 4T1-LFAR and 4T1-HFAR cells incubated with Au / Cu(Ⅱ)PENPs ( Fig.11 Further quantitative analysis revealed that the average fluorescence intensity of 4T1-HFAR cells treated with FA-Au / Cu(II)PENPs was significantly higher than that of 4T1-LFAR cells treated with FA-Au / Cu(II)PENPs (p<0.001, Fig.11 (f) The above results indicate that FA-Au / Cu(II)PENPs modified with FA can be specifically taken up by 4T1-HFAR cells, achieving high enrichment in 4T1-HFAR cells.

[0081] (9) Laser scanning confocal microscopy test results

[0082] CLSM can be used to visually observe the FI fluorescence in the nanocomposite taken up by 4T1 cells, so it can also be used to verify the targeting of FA-Au / Cu(II)PENPs to 4T1 cells. First, the 4T1 cells inoculated in a 12-well plate were divided into two groups, one group was added with a medium containing FA (2.5 μM), and the other group was added with an equal volume of medium without FA and incubated for 2 hours. After the incubation, the medium was removed and washed to obtain 4T1-LFAR cells and 4T1-HFAR cells, respectively. Subsequently, the medium containing FA-Au / Cu(II)PENPs, Au / Cu(II)PENPs and PBS at a concentration of 5 μM was added to the above 4T1-LFAR and 4T1-HFAR cells, respectively, and incubated for 2 hours. After the incubation, the medium was removed and washed 2-3 times with PBS. Then, at 4°C, add 500 μL of 2.5% glutaraldehyde to each well to fix the cells for 20 minutes, and wash the cells 2-3 times with cold PBS to remove the glutaraldehyde. Then, add 1 mL of 1 μg / mL Hoechst 33342 staining solution at room temperature in the dark, stain the cells for 25 minutes, and wash with PBS to remove excess dye. Finally, use the CLSM system to observe and photograph each cell sample. Since FA-Au / Cu(II)PENPs are modified with FI, which has a fluorescent tracer effect, the uptake of the nanomaterial by 4T1-LFAR cells and 4T1-HFAR cells can be intuitively seen through CLSM. The results are shown in Figure 2. Fig.12 As shown in the figure, only weak green fluorescence was present in both 4T1-HFAR and 4T1-LFAR cells incubated with Au / Cu(II)PENPs medium, and the green fluorescence in 4T1-LFAR cells incubated with FA-Au / Cu(II)PENPs was also weak, while the green fluorescence intensity in 4T1-HFAR cells incubated with FA-Au / Cu(II)PENPs was the strongest, and the fluorescence was mainly distributed in the cytoplasm. The results showed that 4T1-HFAR cells could efficiently take up FA-Au / Cu(II)PENPs based on the specific binding of FA to FA receptors on the surface of 4T1 cells.

[0083] (10) Inductively coupled plasma emission spectroscopy test results

[0084] Since FA-Au / Cu(II)PENPs contain gold, the content of gold in 4T1-LFAR cells and 4T1-HFAR cells incubated with FA-Au / Cu(II)PENPs was tested by ICP-OES, which can indirectly reflect the uptake of FA-Au / Cu(II)PENPs by 4T1 cells. Referring to the method in the above test, 4T1-LFAR cells and 4T1-HFAR cells were prepared respectively. Subsequently, the prepared fresh culture medium containing FA-Au / Cu(II)PENPs with Au concentrations of 0μM, 50μM, 100μM and 200μM was added to 4T1-LFAR cells and 4T1-HFAR cells, respectively, with three parallel samples for each group of cells. After incubation for 2h, the culture medium was removed and washed 2-3 times with PBS to remove the residual culture medium. Subsequently, digestion and centrifugation were performed, and 1mL of aqua regia was added to the cell suspension obtained by centrifugation to lyse the cells for 24h, and finally PBS was added to dilute the cell lysate to 3mL. ICP-OES was used to detect the Au content in each group of cell lysate dilutions. The results are as follows: Fig.13 As shown in the data, the uptake of Au by 4T1-LFAR cells and 4T1-HFAR cells increased with the increase of Au concentration of the incubation material, and when the Au concentration was 50μM, 100μM, and 200μM, the uptake of Au by 4T1-HFAR cells was significantly greater than that by 4T1-LFAR cells (p<0.05), further indicating that the synthesized FA-Au / Cu(II)PENPs had a targeting effect on 4T1-HFAR cells, thereby increasing the uptake of FA-Au / Cu(II)PENPs by 4T1-HFAR cells.

[0085] (11) Targeted 4T1 cell CT imaging test results

[0086] Based on the good X-ray attenuation properties of gold nanoparticles and the targeting of FA-Au / Cu(II)PENPs to FA receptor-highly expressed cancer cells, the in vitro targeting CT imaging performance of FA-Au / Cu(II)PENPs to 4T1 cells was further tested. 6Cell density of cells / well 4T1 cells were inoculated in a 6-well plate and incubated for 12 hours. Before the end of cell incubation, cell culture media containing FA-Au / Cu(II)PENPs and Au / Cu(II)PENPs with different Au concentrations ([Au]=0, 25, 50, 100, 200 μM) were prepared. The original culture medium was removed and the newly prepared culture medium containing the above materials was added. After incubating 4T1 cells for 2 hours, the culture medium was removed, and then washed with PBS 2-3 times to remove the residual culture medium, and 4T1 cells (n=3) incubated with FA-Au / Cu(II)PENPs and Au / Cu(II)PENPs with different Au concentrations were obtained. After trypsin digestion for 3-5 minutes, fresh culture medium was added to terminate digestion, and then the cells were suspended by blowing. The suspended cells were then transferred to a centrifuge tube, centrifuged, the supernatant was discarded, and the cells were resuspended with 100 μL PBS. Finally, the CT imaging system was used to scan and image each group of cells and record the corresponding CT values. like Fig.14 As shown in a, it was found that with the increase of gold concentration, the CT imaging brightness of 4T1 cells incubated with FA-Au / Cu(II)PENPs and Au / Cu(II)PENPs gradually increased. In order to more clearly distinguish the difference in CT image brightness between the two groups of cells, the CT signal values ​​of each group of cells were quantitatively analyzed. It was found that when the gold concentration was 200μM, the CT signal value of 4T1 cells incubated with FA-Au / Cu(II)PENPs was 66.7, which was significantly higher than the CT signal value of 4T1 cells incubated with Au / Cu(II)PENPs (49.97) (p<0.01, Fig.14 The above results indicate that based on the targeting interaction between FA and FA receptors on the surface of 4T1 cells, 4T1 cells can take up a high amount of FA-Au / Cu(II)PENPs, thus showing a 4T1 cell CT imaging performance that is superior to that of Au / Cu(II)PENPs.

[0087] (12) Targeted 4T1 cell MR imaging test results

[0088] Similarly, the T1-weighted MR performance of 4T1 cells after incubation of FA-Au / Cu(II)PENPs and Au / Cu(II)PENPs for 2 h was further tested. 6Cell density of cells / well 4T1 cells were seeded in a 6-well plate and cultured overnight. After the cells adhered to the wall and grew, the original culture medium was removed and newly prepared culture medium containing FA-Au / Cu(II)PENPs and Au / Cu(II)PENPs with different copper ion concentrations ([Cu]=0, 25, 50, 100 and 150 μM) was added. After incubation for 2 hours, the culture medium was removed and washed 2-3 times with PBS to obtain 4T1 cells (n=3) incubated with FA-Au / Cu(II)PENPs and Au / Cu(II)PENPs with different Cu concentrations. After digestion, centrifugation, collection, and resuspending the cells with 100 μL PBS, the 4T1 cell suspension incubated with different materials was finally subjected to in vitro MR imaging using an MR imaging system. Fig.15 As shown in Figure 2, within the copper concentration range studied, the pseudo-color MR imaging signal intensity of 4T1 cells was positively correlated with the copper concentration in the culture medium ( Fig.15 In addition, by quantitatively analyzing the corresponding MR imaging signal values, it was found that when the copper concentration was 100 and 150 μM, the MR signal values ​​of 4T1 cells incubated with FA-Au / Cu(II)PENPs were 33.1 and 56.7, respectively, which were significantly higher than the MR signal values ​​of 4T1 cells incubated with Au / Cu(II)PENPs at the same concentration (p<0.05, Fig.15 The above results prove that the modification of FA not only improves the CT imaging performance of FA-Au / Cu(II)PENPs targeting 4T1 cells, but also improves the T1-weighted MR imaging effect of FA-Au / Cu(II)PENPs targeting 4T1 cells, indicating that FA-Au / Cu(II)PENPs can achieve targeted CT / MR imaging of cancer cells.

[0089] (13) CCK-8 test and cell morphology analysis results

[0090] Due to the complexation of copper ions, in order to evaluate the in vitro CDT therapeutic effect of FA-Au / Cu(II)PENPs and Au / Cu(II)PENPs on cancer cells, the present invention uses CCK-8 test for analysis. First, 1.0×10 44T1 cells were inoculated at a density of 5% CO2 and incubated overnight in a 37°C incubator. After the cells adhered to the wall and grew, the culture medium was discarded. After that, each well was replaced with 100 μL of FA-Au PENPs, Au PENPs with different PEI.NH2 concentrations (0, 0.08, 0.16, 0.8, 1.6, 8, 16 μM) and DMEM fresh culture medium containing FA-Au / Cu(II)PENPs, Au / Cu(II)PENPs, CuCl2 with different copper concentrations (0, 5, 10, 50, 100, 500 and 1000 μM), 3 parallel samples for each concentration. After incubation for 24 hours, the original culture medium was discarded, and 100 μL of serum-free culture medium containing 10% CCK-8 was added to each well, and culture was continued for 4 hours. After the culture is completed, the cell culture plate is placed in a multifunctional microplate reader to test the absorbance value at the detection wavelength (450nm) and calculate the cell survival rate. Fig.16 As shown in the figure, within the experimental concentration range, the viability of 4T1 cells incubated with FA-Au PENPs and Au PENPs without Cu(II) complex was greater than 80%, indicating that the functionalized hyperbranched polyethyleneimine-coated gold nanoparticles have good cell compatibility as a carrier ( Fig.16 (a). At each copper concentration (0, 5, 10, 50, 100, 500 and 1000 μM) corresponding to each PEI.NH2 concentration (0, 0.08, 0.16, 0.8, 1.6, 8, 16 μM), the viability of 4T1 cells incubated with FA-Au / Cu(II)PENPs and Au / Cu(II)PENPs gradually decreased with the increase of copper ion concentration, indicating that within a certain concentration range, FA-Au / Cu(II)PENPs and Au / Cu(II)PENPs have obvious in vitro anticancer effects, which are similar to the in vitro anticancer effects of CuCl2, indicating that the cancer cell inhibition effect is only related to copper ions. In particular, when the copper ion concentration was 1000 μM, the viability of 4T1 cells incubated with FA-Au / Cu(II)PENPs was significantly lower than that of 4T1 cells incubated with Au / Cu(II)PENPs (p<0.001, Fig.16 (b) This is because the targeting specificity of FA and FA receptors can increase the uptake of FA by 4T1, making FA-Au / Cu(II)PENPs more effective in inhibiting 4T1 cells and having an in vitro targeted cancer cell CDT therapeutic effect.

[0091] In addition, the present invention also observes the morphology of 4T1 cells by an inverted biological microscope to intuitively evaluate the cytotoxicity of FA-Au / Cu(II)PENPs. 4The cell density of cells / well was 4T1 cells seeded in a 96-well plate and incubated with DMEM medium overnight. Before the end of the cell incubation, cell culture media containing FA-AuPENPs, Au PENPs with a PEI.NH2 concentration of 16μM and FA-Au / Cu(II)PENPs, Au / Cu(II)PENPs, and CuCl2 with a copper ion concentration of 1000μM were prepared, and a culture medium prepared with an equal volume of PBS was used as a control. After the 4T1 cell incubation was completed, the original culture medium was removed and the above-mentioned newly prepared culture medium containing each material was added. After incubating the cells for 24 hours, the culture medium was removed, and then washed 2-3 times with PBS to remove the residual culture medium. Six groups of 4T1 cells with different treatments were obtained and photographed with an inverted biological microscope. The results are shown in Fig.17 As shown, the 4T1 cells treated with FA-Au PENPs and Au PENPs had similar morphology to the 4T1 cells treated with PBS and had good growth status ( Fig.17 ac). However, 4T1 cells treated with FA-Au / Cu(II)PENPs, Au / Cu(II)PENPs and CuCl2 all showed obvious signs of apoptosis, and the degree of apoptosis in 4T1 cells treated with FA-Au / Cu(II)PENPs was greater than that in 4T1 cells treated with Au / Cu(II)PENPs ( Fig.17 The above experimental results are similar to those of the CCK-8 experiment, indicating that FA-Au / Cu(II)PENPs and Au / Cu(II)PENPs after complexing with copper ions have certain cytotoxicity, and FA modification further increases the CDT therapeutic effect of FA-Au / Cu(II)PENPs on 4T1 cells.

[0092] (14) Cell apoptosis test results

[0093] To avoid FI fluorescence interference, FA-Au / Cu(II)PENPs without FI modification were used for cell double staining experiments and tested using Annexin V-FITC / PI apoptosis detection kit. 54T1 cells were seeded in a 12-well plate at a density of cells / well and cultured overnight. After the cells adhered and grew, the culture medium was replaced with fresh culture medium containing FA-Au / Cu(II)PENPs, CuCl2 and PBS with different copper ion concentrations (10, 100 μM), and the incubation continued for 24 hours. After the incubation, the cell samples in the well plate were washed, digested and collected, and the cells in each well were resuspended in 195 μL pre-cooled Annexin V-FITC binding solution, and then 5 μL Annexin V-FITC and 10 μL PI staining solution were added to each sample in turn, and incubated in the dark at room temperature for 15 minutes, and finally tested and analyzed using a flow cytometer. The results are shown in the figure. Fig.18 As shown in the figure, 4T1 cells incubated with FA-Au / Cu(II)PENPs and CuCl2 showed different degrees of apoptosis, and the apoptosis induced by FA-Au / Cu(II)PENPs was more obvious than that induced by CuCl2 at the same copper ion concentration ( Fig.18 (a). After double staining test, the cells in different partitions in flow cytometry analysis were counted, and it was found that with the increase of copper ion concentration, the percentage of live cells after incubation with FA-Au / Cu(II)PENPs and CuCl2 gradually decreased, while the percentage of early apoptotic cells and late apoptotic cells gradually increased. When the copper ion concentration was 10 and 100 μM, the percentage of live cells in 4T1 cells incubated with FA-Au / Cu(II)PENPs was significantly lower than that in 4T1 cells incubated with CuCl2 at the same copper ion concentration, while the percentage of early apoptotic cells and late apoptotic cells in 4T1 cells incubated with FA-Au / Cu(II)PENPs were significantly higher than those incubated with CuCl2 (p<0.001, Fig.18 This may be due to the targeting specificity of FA-Au PENPs, which increases the uptake of FA-Au / Cu(II)PENPs by 4T1 cells, and FA-Au / Cu(II)PENPs can continuously release copper ions, leading to higher early and late apoptosis rates of 4T1 cells.

[0094] (15) Cellular active oxygen content test results

[0095] To further investigate the mechanism behind FA-Au / Cu(II)PENPs-induced apoptosis of 4T1 cells, flow cytometry was used to test the ROS content in 4T1 cells measured by 2,7-dichlorofluorescein diacetate (DCFH-DA) probe. Similarly, FA-Au / Cu(II)PENPs without FI modification were used to avoid the interference of FI's own fluorescence on the experimental results. First, 4T1 cells were cultured at 2.0×10 5The cells were seeded at a density of 10 cells / well in a 12-well plate and cultured overnight. After the cells adhered to the wall and grew, the culture medium was discarded, and FA-Au / Cu(II)PENPs, CuCl2 and PBS culture medium containing different copper ion concentrations (10, 100 μM) were added and incubated for 5 hours. The 4T1 cells were then washed with PBS, and 1 mL of serum-free culture medium containing 10 μM DCFH-DA probe was added, and incubated in the dark for 40 minutes. A total of 5 groups of cells were obtained. Afterwards, the cells were washed, digested and collected for flow cytometry analysis. The results are shown in Fig.19 As shown in the figure, compared with the fluorescence signal of ROS generated in 4T1 cells treated with PBS, the fluorescence intensity of ROS generated in 4T1 cells treated with CuCl2, FA-Au / Cu(II)PENPs ([Cu] = 10 μM) and CuCl2, FA-Au / Cu(II)PENPs ([Cu] = 100 μM) was significantly increased, indicating that CuCl2 and FA-Au / Cu(II)PENPs can induce 4T1 cells to produce reactive oxygen species ( Fig.19 Quantitative analysis of the flow cytometry results revealed that the relative reactive oxygen level in 4T1 cells treated with FA-Au / Cu(II)PENPs at a copper ion concentration of 100 μM was 12.9, which was significantly higher than the relative reactive oxygen level in 4T1 cells treated with 100 μM CuCl2 (8.3, p<0.001), indicating that FA-Au / Cu(II)PENPs can produce a large amount of ·OH in 4T1 cells, which is about 13 times that of PBS-treated 4T1 cells ( Fig.19 (b) This is similar to the results of the cell apoptosis test, indicating that FA-Au / Cu(II)PENPs induced ·OH produced by 4T1 cells, leading to 4T1 cell apoptosis.

[0096] (16) Hemolysis test results

[0097] Blood compatibility is another important indicator for the safety evaluation of nanomaterials. Therefore, the present invention uses a hemolysis experiment to evaluate the blood compatibility of FA-Au / Cu(II)PENPs in Example 1. First, add the mouse blood obtained by the mouse orbital blood sampling operation into a centrifuge tube containing the anticoagulant sodium heparin, centrifuge, discard the supernatant to collect red blood cells, and wash repeatedly with PBS 3-4 times until the supernatant is colorless. Add 10 times the volume of PBS to the collected red blood cells to prepare a red blood cell suspension. Then take a 1.5mL centrifuge tube, add 100μL of red blood cell suspension to each centrifuge tube, and add 900μL of H2O, PBS and FA-Au / Cu(II)PENPs ([Cu]=2.5, 5, 10, 20, 40μg / mL) PBS solution respectively, and mix well. Let stand for 2h at 37℃, then rotate at a speed of 1×10 4The supernatant was centrifuged at 540 nm to calculate the hemolysis rate. Fig. 20 As shown in the data, compared with the red blood cells treated with H2O, the red blood cells treated with FA-Au / Cu(II)PENPs at different copper concentrations (2.5-40μg / mL) did not show obvious hemolysis, and the hemolysis rate was less than 5%. From the photos in the data, it can be seen that except for the red blood cells treated with H2O, the red blood cells treated with other materials showed no signs of cell rupture, showing the good blood compatibility of FA-Au / Cu(II)PENPs.

Claims

1. Functionalized polyethyleneimine composites with complexed copper ions, It is characterized in that The preparation was carried out by the following steps: Step 1, adding (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide to a dimethyl sulfoxide solution of folic acid for activation, and then adding the solution to a dimethyl sulfoxide solution of amino-polyethylene glycol-carboxyl for reaction to obtain FA-PEG-COOH; Step 2, adding (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide to a solution of 2-picolinic acid in N'N-dimethylformamide for activation, and then adding the solution to an aqueous solution of hyperbranched polyethyleneimine for reaction to obtain PEI.NH 2 -PA; Step 3: Add (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide to the aqueous solution of FA-PEG-COOH for activation, and then add the solution to PEI.NH 2 -PA in aqueous solution to obtain PEI.NH 2 -(PEG-FA)-PA; Step 4: Add the dimethyl sulfoxide solution of fluorescein isothiocyanate to the PEI.NH 2 -(PEG-FA)-PA in dimethyl sulfoxide solution, stir and react in the dark to obtain PEI.NH 2 -FI-(PEG-FA)-PA; Step 5: Add the aqueous solution of chloroauric acid to PEI.NH 2 -FI-(PEG-FA)-PA aqueous solution, stir in the dark, then add sodium borohydride solution, stir in the dark, react; then add triethylamine, stir in the dark, react; then add acetic anhydride, continue to stir in the dark, react, and obtain nanoparticles FA-Au PENPs; Step 6, adding the copper chloride aqueous solution into the aqueous solution of the nanoparticles FA-Au PENPs while stirring and shielding from light, and ultrasonicating to prepare the functionalized polyethyleneimine composite material FA-Au / Cu(II) PENPs complexed with copper ions.

2. The functionalized polyethyleneimine composite material complexed with copper ions according to claim 1, It is characterized in that In step 1, the molar ratio of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, N-hydroxysuccinimide and folic acid is 1-1.5:1-1.5:1, and the molar ratio of folic acid to amino-polyethylene glycol-carboxyl is 1.2-1.5:

1.

3. The functionalized polyethyleneimine composite material of complex copper ions according to claim 1, It is characterized in that In step 2, the molar ratio of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, N-hydroxysuccinimide and 2-picolinic acid is 10-12:10-12:1, and the molar ratio of 2-picolinic acid to hyperbranched polyethyleneimine is 80-100:

1.

4. The functionalized polyethyleneimine composite material of complex copper ions according to claim 1, It is characterized in that In step 3, the molar ratio of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, N-hydroxysuccinimide and FA-PEG-COOH is 10-12:10-12:1, and the molar ratio of FA-PEG-COOH to PEI.NH 2 -PA has a molar ratio of 20-25:

1.

5. The functionalized polyethyleneimine composite material of complex copper ions according to claim 1, It is characterized in that In step 4, fluorescein isothiocyanate and PEI.NH 2 The molar ratio of -(PEG-FA)-PA is 3-5:

1.

6. The functionalized polyethyleneimine composite material of complex copper ions according to claim 1, It is characterized in that Step 5: Chloroauric acid and PEI.NH 2 The molar ratio of -FI-(PEG-FA)-PA is 100:1, the molar ratio of sodium borohydride to chloroauric acid is 3-5:1, and the molar ratio of triethylamine, acetic anhydride and PEI.NH 2 The molar ratio of -FI-(PEG-FA)-PA is 120-660:100-550:

1.

7. The functionalized polyethyleneimine composite material with complexed copper ions according to claim 1, It is characterized in that In step 6, the molar ratio of copper chloride to nanoparticles FA-Au PENPs is 60:

1.

8. Use of the functionalized polyethyleneimine composite material complexed with copper ions according to claim 1 in the preparation of tumor diagnosis and treatment reagents.